Type 2 diabetes mellitus complicated by acquired reactive perforating collagenosis: A case report and literature review
Abstract
Rationale: Acquired reactive perforating collagenosis (ARPC) is a perforating skin disorder characterized by transepidermal elimination of degenerated collagen. It is often associated with systemic diseases, such as diabetes and chronic kidney disease. Due to its diverse clinical manifestations, ARPC is often misdiagnosed or overlooked in clinical practice.
Patient concerns: A 66-year-old female with a 22-year history of type 2 diabetes (T2DM) was admitted to the hospital due to poor blood glucose control. She had been experiencing itching and a rash for nearly 3 months and had previously been treated at another hospital, but the response was unsatisfactory. Physical examination revealed erythema, papules, and nodules on the extensor surfaces of both lower extremities.
Diagnoses: The patient had a confirmed diagnosis of T2DM. Histopathological examination of the skin lesion revealed collagen fibers penetrating through the epidermis, which were positive for Van Gieson staining. Therefore, the final diagnosis was T2DM complicated by ARPC.
Interventions: Oral antihistamines and topical corticosteroid cream were given along with blood glucose control.
Outcomes: After the aforementioned treatment, the patient's blood glucose level was well controlled, the skin lesions gradually healed, and the pruritus significantly subsided.
Lessons: This case suggests that the occurrence of ARPC may be closely related to persistent hyperglycemia. ARPC skin lesions can be regarded as one of the…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.